Skin Treatment (Pharmacies) - Taiwan

  • Taiwan
  • Revenue in the Skin Treatment market is projected to reach US$97.39m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 6.92%, resulting in a market volume of US$136.10m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$3,319.00m in 2024).
  • In relation to total population figures, per person revenues of US$4.07 are generated in 2024.

Key regions: Germany, Europe, South Korea, France, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Skin Treatment (Pharmacies) market in Taiwan is experiencing significant growth due to changing customer preferences and trends in the market.

Customer preferences:
Customers in Taiwan have shown a growing interest in skincare and are increasingly seeking out skin treatment products from pharmacies. This shift in preference can be attributed to several factors. Firstly, there is a growing awareness among consumers about the importance of skincare and the impact it has on overall health and well-being. As a result, more people are investing in skincare products to address specific skin concerns and maintain a youthful appearance. Additionally, the convenience of purchasing skin treatment products from pharmacies, which are easily accessible and offer a wide range of options, has also contributed to the increased demand.

Trends in the market:
One of the key trends in the Skin Treatment (Pharmacies) market in Taiwan is the rising popularity of natural and organic skincare products. Consumers are becoming more conscious of the ingredients used in skincare products and are actively seeking out products that are free from harmful chemicals and additives. This trend is driven by a desire for safer and more sustainable skincare options. As a result, pharmacies in Taiwan are stocking a larger variety of natural and organic skin treatment products to cater to this growing demand. Another trend in the market is the increasing adoption of advanced skincare technologies. Taiwanese consumers are known for their interest in technological advancements, and this extends to the skincare industry as well. Products that incorporate innovative technologies such as LED therapy, microcurrents, and ultrasonic waves are gaining popularity in the market. These technologies offer targeted and effective solutions for various skin concerns, and customers are willing to invest in these advanced treatments to achieve desired results.

Local special circumstances:
Taiwan has a strong pharmaceutical industry and a well-developed healthcare system, which contributes to the growth of the Skin Treatment (Pharmacies) market. The country has a high standard of healthcare and a strong emphasis on preventive care, which includes skincare. This cultural emphasis on health and wellness drives the demand for skin treatment products in pharmacies.

Underlying macroeconomic factors:
Taiwan has a stable economy with a high disposable income among its population. This allows consumers to allocate a significant portion of their budget towards skincare and beauty products. Additionally, the aging population in Taiwan has contributed to the growth of the skin treatment market, as older individuals are more likely to invest in skincare products to address age-related skin concerns. In conclusion, the Skin Treatment (Pharmacies) market in Taiwan is experiencing growth due to changing customer preferences and trends in the market. Customers in Taiwan are increasingly seeking out skincare products from pharmacies, driven by a growing awareness of skincare and the convenience of purchasing from pharmacies. The market is also influenced by trends such as the popularity of natural and organic skincare products and the adoption of advanced skincare technologies. Additionally, Taiwan's strong pharmaceutical industry, well-developed healthcare system, and stable economy contribute to the growth of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)